Scienture Holdings, Inc. (SCNX)
NASDAQ: SCNX · Real-Time Price · USD
0.2648
-0.0126 (-4.54%)
Sep 28, 2026, 11:23 AM EDT - Market open
Scienture Holdings Revenue
Scienture Holdings had revenue of $343.64K in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $821.32K, up 540.64% year-over-year. In the year 2025, Scienture Holdings had annual revenue of $431.61K with 215.87% growth.
Revenue (ttm)
$821.32K
Revenue Growth
+540.64%
P/S Ratio
13.87
Revenue / Employee
$91,257
Employees
9
Market Cap
10.87M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 431.61K | 294.97K | 215.87% |
| Dec 31, 2024 | 136.64K | -1.23M | -89.98% |
| Dec 31, 2023 | 1.36M | -8.89M | -86.69% |
| Dec 31, 2022 | 10.25M | 360.74K | 3.65% |
| Dec 31, 2021 | 9.89M | -7.23M | -42.24% |
| Dec 31, 2020 | 17.12M | 9.69M | 130.26% |
| Dec 31, 2019 | 7.44M | 3.60M | 94.07% |
| Dec 31, 2018 | 3.83M | 900.50K | 30.72% |
| Dec 31, 2017 | 2.93M | 449.41K | 18.11% |
| Dec 31, 2016 | 2.48M | -430.66K | -14.79% |
| Dec 31, 2015 | 2.91M | 1.42M | 94.66% |
| Dec 31, 2014 | 1.50M | 540.35K | 56.53% |
| Dec 31, 2013 | 955.88K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Johnson & Johnson | 97.93B |
| Eli Lilly and Company | 79.67B |
| Merck & Co. | 66.57B |
| AbbVie | 64.39B |
| Healthcare Triangle | 25.67M |
| Moolec Science | 7.83M |
| BioLineRx | 1.39M |
| CytoMed Therapeutics | 669.28K |
SCNX News
- 5 hours ago - DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application - Accesswire
- 3 days ago - DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit - Accesswire
- 6 days ago - Scienture expands commercial reach of Rexenopy to Addiction Treatment Centers - TheFly
- 6 days ago - SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner - GlobeNewsWire
- 7 days ago - DataMEDS AI Unveils New Corporate Website - Accesswire
- 10 days ago - DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked - Accesswire
- 11 days ago - This AI stock experienced a 5x rally on Wednesday - Invezz
- 12 days ago - DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute - Accesswire